How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy
Methotrexate (MTX) is a remarkable drug with a key role in the management of rheumatoid arthritis (RA) at every stage of its evolution. Its attributes include good overall efficacy for signs and symptoms, inhibition of structural damage and preservation of function with acceptable and manageable saf...
Main Authors: | Taylor, P, Criado, AB, Mongey, A-B, Avouac, J, Marotte, H, Mueller, RB |
---|---|
פורמט: | Journal article |
יצא לאור: |
MDPI
2019
|
פריטים דומים
-
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
מאת: Zhang L, et al.
יצא לאור: (2020-12-01) -
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
מאת: Wulffraat NM, et al.
יצא לאור: (2011-09-01) -
International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector
מאת: Müller-Ladner U, et al.
יצא לאור: (2024-03-01) -
Methotrexate (MTX) failed to control giant cell arteritis (GCA)
מאת: Hoffman, G, et al.
יצא לאור: (2001) -
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
מאת: Jing Zhang, et al.
יצא לאור: (2020-10-01)